// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Role of the pleural clinical nurse specialist in improving the patient pathway

Laura Mcnaughton - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Improving patient communication and nursing training in bronchoscopy

Cielito Caneja - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Switching to maintenance and reliever inhaled corticosteroid/long acting beta agonist: a real-world pilot evaluation in a regional paediatric difficult asthma clinic

May Al-moasseb - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

The cost of the clinic visit - a short research project exploring the cost of clinic appointments, financial and otherwise, to families visiting Alder Hey Children's Hospital

Bethan Chadwick - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What influences patient choice of antifibrotic treatment in IPF?

Emma Briggs - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Pirfenidone

Hospital at home for hypoxaemic patients: extending the remit of community respiratory care

Emma Rickards - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IPF risk: two's company, three's a crowd? Asbestos exposure, cigarette smoke, and MUC5B promoter polymorphism rs35705950. Findings from the idiopathic pulmonary fibrosis job exposures study (IPFJES

Carl Reynolds - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Using digital and social media to highlight the risks of occupational exposures as a cause of lung diseases

David Fishwick - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Occupational Exposures and Incidence of ASTHMA Over Two Decades in the ECRHS

Sheikh Alif - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

No evidence electric charge increases inhaled ultrafine particle deposition in human lungs

Martyn Biddiscombe - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interstitial Lung Disease (ILD in aluminium welders

Johanna Feary - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Impact of air pollutant of polycyclic aromatic hydrocarbons (PAHs on the yearly decline of pulmonary in patients with asthma

Chun-Hua Wang - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Relationship between ambient air pollution and lung function in a Canadian population: the CanCOLD cohort study

Dany Doiron - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Use of biomass cooking fuel and risk of respiratory symptoms and Acute Respiratory Infections in Ugandan children aged under 5 years: cross-sectional analysis

Katherine Woolley - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

N/A

Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis

Ngamjit Kongsupon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Extrinsic allergic alveolitis

N/A

Breathing pattern disorder masquerading as occupational asthma

Johanna Feary - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Around the world usage of the Oasys serial PEF plotter for the diagnosis of occupational asthma

Vicky Moore - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

An evaluation of peak expiratory flow measured on the smart peak flow meter

Shirley Coelho - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Farming and respiratory health: a cross-sectional study in Thailand

Jate Ratanachina - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of controller prescribing according to rs1042713 genotype on asthma related quality of life in young people (PACT: a randomized controlled trial

Thomas Ruffles - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved